CWM
BIIB icon

Cabot Wealth Management’s Biogen BIIB Stock Holding History

Cabot Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-663
Closed -$268K – 138
2015
Q2 		$268K Sell
663
-5,200
-89% -$2.09M 0.07% 134
2015
Q1 		$2.48M Sell
5,863
-2,133
-27% -$841K 0.6% 67
2014
Q4 		$2.71M Sell
7,996
-2,022
-20% -$654K 0.67% 67
2014
Q3 		$3.31M Sell
10,018
-492
-5% -$162K 0.85% 56
2014
Q2 		$3.31M Sell
10,510
-59
-0.6% -$17.8K 0.83% 57
2014
Q1 		$3.23M Sell
10,569
-42
-0.4% -$13.3K 0.85% 53
2013
Q4 		$2.97M Sell
10,611
-91
-0.9% -$23.5K 0.78% 60
2013
Q3 		$2.58M Sell
10,702
-141
-1% -$31.6K 0.77% 65
2013
Q2 		$2.33M Buy
+10,843
New +$2.32M 0.8% 50

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Cabot Wealth Management's BIIB Position: Q3 2015 in Review

Cabot Wealth Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 663 shares — an estimated $268K sold.

Cabot Wealth Management first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $3.31M in Q3 2014. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Cabot Wealth Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Cabot Wealth Management sold 663 Biogen shares in Q3 2015, an estimated $268K.
  • Cabot Wealth Management first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
  • Cabot Wealth Management's Biogen position peaked at $3.31M in Q3 2014.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Cabot Wealth Management's 13F filing for Q3 2015, filed 3 Nov 2015.